-
News & Events
1月29日下午，仁医医疗四人团队来到哥廷根大学医疗中心拜访神经内科主任、德国国家科学院院士、哥廷根大学心脑中心（HBCG）创始主任Bähr教授。我们首先与他讨论了他2024年客座教授及其三位临床医学MD博士的工作安排。随后Bähr教授带我们参观了心脑中心。2017年，Bähr教授牵头向主管科研机构发展及建设的德国科学与人文委员会申请了资金，并最终获得3500万欧元预算用于心脑中心的建设。心脑中心占地约6000平方米，由Bähr教授和建筑师团队共同打造并于2023年5月正式开放运营。Bähr教授介绍道，哥廷根大学心脑中心是由神经内科、心肺科、老年医学及认知神经病学研究所联合创立的研究大楼，目标是密切合作，共同探索超越人体器官边界的系统医学方法，对心脏及神经疾病进行新分型、分类，开发新的诊断方法、治疗方法、预防方法。同时也是为了将相关临床学科进行整合、互相支持、进行概念验证（POC）研究、创立新的跨学科科室及研究工作组并提供教育项目，更好培养下一代医学领军人才。心脑中心根植于卓越的科研环境，其科研咨询委员会由哥廷根大学医疗中心科研委员会、下萨克森州创新联合会、德国国家神经退行性疾病中心、多尺度生物成像卓越集群、德国心血管科研中心、哥廷根大学研究生院等组成。Bähr教授还为我们详细介绍了每个研究小组现在承担的主要项目，并亲自带领我们参观每个研究小组的办公室、实验室、细胞实验室、动物实验室、实时MR室等。我们感叹于Bähr教授及其团队仅用6年时间，3500万欧元预算，就将如此庞大、学科设置齐全、设备精良的研究所落地的同时，也深刻感受到哥廷根大学乃至整座城市的科研和学术氛围，同时非常感谢Bähr教授及其团队花了6小时的时间接待我们团队。2024年11月Bähr教授将到访如梦如幻的中国苏州，担任2024中欧医院管理学科建设人才培养全球论坛欧洲区主席并主持学科建设环节，分享他对神经内科、心脑研究、基础科研转化等方面的深刻见解。
In the afternoon of January 29th, the team of four from Gloryren arrived at the University Medical Center Göttingen to visit Prof. Bähr, the Director of the Neurology Department, Fellow of German National Academy of Sciences Leopoldina, and the Founding Director of the Heart and Brain Center Göttingen (HBCG). We first discussed his work arrangement for 2024 visiting professorship and his three MD students. Then, Prof. Bähr showed us around the HBCG. In 2017, Prof. Bähr led a team to apply for a funding from the German Science and Humanities Council (WR) who takes charge of the development and construction of scientific research institutes. Eventually they were funded 35 million euros for the construction of the HBCG. The HBCG covers an area of about 6,000 square meters. It was the result of hard work of Prof. Bähr and a team of architects, and started to function since May, 2023. Prof. Bähr introduced to us that the HBCG is a research building co-founded by the Departments of Neurology, Cardiology and Pneumology, and Geriatrics, and the Institute for Cognitive Neurology. The aim of founding the HBCG is to establish a close collaboration to jointly explore systems medicine approaches beyond organ borders, new classifications of heart and brain disorders, innovative diagnostic approaches, and new prevention and therapy concepts. Meanwhile, it also aims to integrate related clinical specialties, enhance support structures, facilitate proof of concept (POC) studies, establish new interdisciplinary departments and junior groups, and offer educational programs for a better cultivation of medical leading talents for the next generation. The HBCG is rooted in an outstanding scientific environment. Its Scientific Advisory Board (SAB) consists of the Research Committee of the University Medical Center Göttingen, Southern Lower Saxony Innovations Campus (SNIC), German Center for Neurodegenerative Diseases (DZNE), Multiscale Bioimaging Cluster of Excellence (MBExC), German Centre for Cardiovascular Research (DZHK), the Graduate School of the University of Göttingen, etc. Prof. Bähr also introduced the main projects of every research group to us in detail, and personally showed us around every group's office, laboratory, cell lab, animal lab, real-time MR room, and so on. We were amazed by the great achievements of Prof. Bähr and his team in building such a large, multidisciplinary, and well-equipped research institute with only 35 million euros in merely 6 years. Meanwhile, we deeply felt the research and academic atmosphere in the University of Göttingen and the whole city. We also very much appreciated that Prof. Bähr and his team spent six hours accompanying our team. In November of 2024, Prof. Bähr will visit the dreamlike city of Suzhou, China. He will serve as the European President on the 2024 Sino-Euro Global Forum on Hospital Management, Specialty Construction and Talent Cultivation, host the Specialty Construction Session, and share his insights into multiple aspects, such as neurology, heart and brain research, and translational research.
